Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 5
1963 11
1964 21
1965 32
1966 28
1967 26
1968 15
1969 20
1970 9
1971 14
1972 8
1973 15
1974 17
1975 11
1976 18
1977 14
1978 15
1979 9
1980 17
1981 10
1982 19
1983 17
1984 38
1985 38
1986 39
1987 37
1988 37
1989 29
1990 30
1991 28
1992 25
1993 10
1994 14
1995 5
1996 5
1997 2
1998 6
1999 4
2000 1
2001 4
2002 1
2003 4
2004 2
2005 1
2006 2
2011 1
2012 1
2013 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

717 results

Results by year

Filters applied: . Clear all
Page 1
Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis.
Jongkhajornpong P, Anothaisintawee T, Lekhanont K, Numthavaj P, McKay G, Attia J, Thakkinstian A. Jongkhajornpong P, et al. Cornea. 2022 Sep 1;41(9):1137-1149. doi: 10.1097/ICO.0000000000002943. Epub 2021 Dec 20. Cornea. 2022. PMID: 34924549 Free PMC article.
Cord blood serum was the most effective treatment for increasing tear break-up time (USMD 2.67; 95% CI: 0.53-4.82), and eledoisin was superior to others in improving Schirmer scores (USMD 2.28; 95% CI: 0.14-4.42). ...
Cord blood serum was the most effective treatment for increasing tear break-up time (USMD 2.67; 95% CI: 0.53-4.82), and eledoisin was …
Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study.
Nebbioso M, Evangelista M, Librando A, Plateroti AM, Pescosolido N. Nebbioso M, et al. Biomed Pharmacother. 2013 Sep;67(7):659-63. doi: 10.1016/j.biopha.2013.07.001. Epub 2013 Jul 12. Biomed Pharmacother. 2013. PMID: 23906760 Clinical Trial.
BACKGROUND: To evaluate the effects of an eye drop containing eledoisin and carnitine in patients suffering from primary open-angle glaucoma (POAG) and ocular discomfort syndrome secondary to a chronically treated with eye drops containing benzalkonium chloride (BAK) as pr …
BACKGROUND: To evaluate the effects of an eye drop containing eledoisin and carnitine in patients suffering from primary open-angle g …
Structural heterogeneity of doubly-charged peptide b-ions.
Li X, Huang Y, O'Connor PB, Lin C. Li X, et al. J Am Soc Mass Spectrom. 2011 Feb;22(2):245-54. doi: 10.1007/s13361-010-0036-1. Epub 2011 Jan 29. J Am Soc Mass Spectrom. 2011. PMID: 21472584 Free PMC article.
Sequence scrambling was observed in ECD of all b-ions from neurokinin A (HKTDSFVGLM-NH(2)), suggesting the presence of N- and C-termini linked macro-cyclic conformers. On the contrary, none of the b-ions from eledoisin (pEPSKDAFIGLM-NH(2)) produced non-direct sequence ions …
Sequence scrambling was observed in ECD of all b-ions from neurokinin A (HKTDSFVGLM-NH(2)), suggesting the presence of N- and C-termini link …
Regulation of the stimulant actions of neurokinin a and human hemokinin-1 on the human uterus: a comparison with histamine.
Pennefather JN, Patak E, Ziccone S, Lilley A, Pinto FM, Page NM, Story ME, Grover S, Candenas ML. Pennefather JN, et al. Biol Reprod. 2006 Sep;75(3):334-41. doi: 10.1095/biolreprod.106.051508. Epub 2006 May 17. Biol Reprod. 2006. PMID: 16707771
The effects of neurokinin A (NKA) and human hemokinin-1 (hHK-1) in tissues from pregnant but not from nonpregnant women were enhanced by the inhibition of neprilysin. The effects of NKA and eledoisin were blocked by the NK2 receptor antagonist SR 48968 but not by the NK1 r …
The effects of neurokinin A (NKA) and human hemokinin-1 (hHK-1) in tissues from pregnant but not from nonpregnant women were enhanced by the …
Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
Rigby M, O'Donnell R, Rupniak NM. Rigby M, et al. J Comp Neurol. 2005 Oct 3;490(4):335-53. doi: 10.1002/cne.20664. J Comp Neurol. 2005. PMID: 16127708
We compared the distribution of NK1, NK2, and NK3 receptors in sections from rodent, primate, and human brain using the 125I-labeled ligands substance P (SP) for the NK1 receptor, neurokinin A (NKA) for the NK2 receptor, and neurokinin B (NKB) and eledoisin for NK3 recepto …
We compared the distribution of NK1, NK2, and NK3 receptors in sections from rodent, primate, and human brain using the 125I-labeled ligands …
Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin.
Lippe C, Bellantuono V, Ardizzone C, Cassano G. Lippe C, et al. Peptides. 2004 Nov;25(11):1971-5. doi: 10.1016/j.peptides.2004.06.014. Peptides. 2004. PMID: 15501529
Therefore, either 2 Pro residues or 1 Pro and 1 basic amino acid must be present in the part exceeding the C-terminal pentapeptide. Eledoisin (NK3 preferring in mammals) stimulation of SCC is reduced by CP99994 and SR48968 (NK1 and NK2 antagonists) and not affected by SB22 …
Therefore, either 2 Pro residues or 1 Pro and 1 basic amino acid must be present in the part exceeding the C-terminal pentapeptide. Eledo …
Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
Johansson A, Liu L, Holmgren S, Burcher E. Johansson A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):35-45. doi: 10.1007/s00210-004-0943-4. Epub 2004 Jul 2. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15235762
Specific binding of [125I]BH-bufokinin was displaced by bufokinin> or =SP>NKA> or =eledoisin approximately kassinin>X-NKA, indicating binding to a tachykinin NK1-like receptor. Selective tachykinin receptor antagonists were weak or ineffective. Other iodinated …
Specific binding of [125I]BH-bufokinin was displaced by bufokinin> or =SP>NKA> or =eledoisin approximately kassinin>X-NKA …
Three-dimensional structure of the mammalian tachykinin peptide neurokinin A bound to lipid micelles.
Chandrashekar IR, Cowsik SM. Chandrashekar IR, et al. Biophys J. 2003 Dec;85(6):4002-11. doi: 10.1016/S0006-3495(03)74814-0. Biophys J. 2003. PMID: 14645089 Free PMC article.
The conformation adopted by NKA in the presence of DPC micelles represents a structural motif typical of neurokinin-2 selective agonists and is similar to that reported for eledoisin in hydrophobic environment....
The conformation adopted by NKA in the presence of DPC micelles represents a structural motif typical of neurokinin-2 selective agonists and …
717 results